Effect of continuous positive airway pressure on homocysteine levels in patients with obstructive sleep apnea: A meta-analysis

Sleep and Breathing

Volumn 18, Issue 4, 2014, Pages 687-694

  Chen, Xiong ^a   Niu, Xun ^a   Xiao, Ying ^a   Dong, Jiaqi ^a   Zhang, Rui ^a   Lu, Meixia ^a   Kong, Weijia ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Continuous positive airway pressure; Homocysteine; Meta analysis; Sleep apnea

Indexed keywords

EID: 84892763619     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-014-0940-x     Document Type: Review

References (35)

1. Ryan CM, Bradley TD (2005) Pathogenesis of obstructive sleep apnea. J Appl Physiol 99:2440–2450
2. Xiao Y, Chen X, Shi H, Yang Y, He L, Dong J, Kong W (2011) Evaluation of airway obstruction at soft palate level in male patients with obstructive sleep apnea/hypopnea syndrome: dynamic 3-dimensional CT imaging of upper airway. J Huazhong Univ Sci Technolog Med Sci 31:413–418
3. Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5:263–276
4. Martinez D, Klein C, Rahmeier L, da Silva RP, Fiori CZ, Cassol CM, Goncalves SC, Bos AJ (2012) Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors. Sleep Breath 16:695–701
5. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034–2041
6. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M (2004) Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol 93:439–453
7. Can M, Acikgoz S, Mungan G, Bayraktaroglu T, Kocak E, Guven B, Demirtas S (2006) Serum cardiovascular risk factors in obstructive sleep apnea. Chest 129:233–237
8. Ozkan Y, Firat H, Simsek B, Torun M, Yardim-Akaydin S (2008) Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 12:149–154
9. Monneret D, Tamisier R, Ducros V, Garrel C, Levy P, Baguet JP, Faure P, Pepin JL (2012) The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome. Respir Physiol Neurobiol 180:298–304
10. Chen M, Wu B, Ye X, Zhou Z, Yue X, Wang Q, Wang W, Jiang Y, Lian X, Chen Z, Xu G, Liu X (2011) Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischaemic stroke. J Clin Neurosci 18:1454–1457
11. Malhotra A, Ayas NT, Epstein LJ (2000) The art and science of continuous positive airway pressure therapy in obstructive sleep apnea. Curr Opin Pulm Med 6:490–495
12. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT (2003) Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 163:565–571
13. D'Ambrosio C, Bowman T, Mohsenin V (1999) Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure—a prospective study. Chest 115:123–129
14. Kumor M, Bielicki P, Przybylowski T, Rubinsztajn R, Zielinski J, Chazan R (2011) Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS). Pneumonol Alergol Pol 79:173–183
15. Cintra F, Tufik S, D’Almeida V, Calegare BF, de Paola A, Oliveira W, Rizzi C, Roizenblatt S, Poyares D (2011) Cysteine: a potential biomarker for obstructive sleep apnea. Chest 139:246–252
16. Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, Froudarakis M, Christaki P, Bouros D (2007) Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132:843–851
17. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62:509–514
18. Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann PD, von Ahsen N, Ruther E, Kornhuber J, Bleich S (2004) CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm 111:683–689
19. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR (2004) Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59:777–782
20. Barcelo A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J, Duran J, Agusti AG (2006) Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27:756–760
21. Rubinsztajn R, Kumor M, Byskiniewicz K, Chazan R (2006) The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome. Pneumonol Alergol Pol 74:63–67
22. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
23. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
25. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
26. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
27. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
28. Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463
29. Petrisor BA, Keating J, Schemitsch E (2006) Grading the evidence: levels of evidence and grades of recommendation. Injury 37:321–327
30. Lavie L, Perelman A, Lavie P (2001) Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest 120:900–908
31. Svatikova A, Wolk R, Magera MJ, Shamsuzzaman AS, Phillips BG, Somers VK (2004) Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 25:1325–1329
32. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053
33. Doherty LS, Kiely JL, Swan V, McNicholas WT (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127:2076–2084
34. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049–1057
35. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S (1999) Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131:363–375